COMPARISON BETWEEN CONCOMITANT CHEMO-RADIOTHERAPY WITH CISPLATIN VERSUS INDUCTION CHEMOTHERAPY FOLLOWED BY CONCOMITANT CHEMORADIOTHERAPY WITH CISPLATIN AND ETOPOSIDE REGIMEN IN C - Egyptian Knowledge Bank

145856

COMPARISON BETWEEN CONCOMITANT CHEMO-RADIOTHERAPY WITH CISPLATIN VERSUS INDUCTION CHEMOTHERAPY FOLLOWED BY CONCOMITANT CHEMORADIOTHERAPY WITH CISPLATIN AND ETOPOSIDE REGIMEN IN C

Article

Last updated: 04 Jan 2025

Overview Similar Items

Article

COMPARISON BETWEEN CONCURRENT CHEMORADIATION WITH VERSUS WITHOUT CHEMOTHERAPY AS BLADDER PRESERVATION PROTOCOL IN MUSCLE INVASIVE BLADDER CANCER

Article

Weekly cisplatin (40 mg/m2) versus three-weekly (100mg/m2) cisplatin delivered concurrently with radiotherapy in high risk head and neck cancer patients

Article

Induction chemotherapy followed by chemoradiation versus upfront chemoradiation in locally advanced head and neck cancers A prospective randomized study

Article

NEOADJUVANT CHEMOTHERAPY FOLLOWED BY CONCURRENT CHEMORADIATION FOR LOCALLY ADVANCED HEAD AND NECK CANCERS

Article

Induction Chemotherapy Versus Upfront Chemoradiation for Locoregionally Advanced of Head and Neck Cancer

Article

Combination of Cisplatin and Temozolomide Versus Carboplatin and Etoposide in the Treatment of Recurrent High Grade Glioma Patients

Article

CONCURRENT CHEMO-RADIOTHERAPY OF WEEKLY PACLITAXEL VERSUS WEEKLY CARBOPLATIN IN LOCALLY ADVANCED HEAD AND NECK CARCINOMAS UNFIT FOR CISPLATIN

Article

Weekly versus every three weeks cisplatin as concurrent chemoradiotherapy in locally advanced head and neck cancer: single institution experience

Article

Induction Chemotherapy Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation alone For Locally Advanced Laryngeal & Nasopharyngeal Cancers: A Retrospective Study

Article

The Outcomes of Concomitant Hypofractionated Simultaneous Integrated Boost Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin monotherapy for Newly Diagnosed Local